Inventor · Écully, FR

Didier Roche

17Patents
2h-index
50Co-inventors
53Inventor score

Filing activity: Oct 11, 2000 → Feb 19, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US6399599B1 Substituted 2-oxo-1,4-diazacycloalkanes Human Necessities 10 Expired
US7582656B2 Guanidine derivatives and therapeutic uses thereof Chemistry; Metallurgy 5 Expired
US7482484B2 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia Chemistry; Metallurgy 1 Expired
US8188288B2 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors Chemistry; Metallurgy 1 Active
US8575161B2 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators Chemistry; Metallurgy 1 Active
US8486964B2 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors Human Necessities 1 Active
US9895380B2 Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection Human Necessities 1 Active
US8466200B2 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors Chemistry; Metallurgy 0 Active
US10071108B2 Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection Human Necessities 0 Active
US7754740B2 1H-indole-3-carboxylic acid derivatives and their use as PPAR agonists Chemistry; Metallurgy 0 Expired
US8586577B2 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors Human Necessities 0 Active
US8242107B2 Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors Human Necessities 0 Active
US10654818B2 Furane derivatives as inhibitors of ATAD2 Chemistry; Metallurgy 0 Active
US8546575B2 NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 Emerging Cross-Sectional Technologies 0 Active
US8183265B2 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors Chemistry; Metallurgy 0 Active
US8765728B2 [1,5]-diazocin derivatives Chemistry; Metallurgy 0 Active
US8470849B2 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.